About The Cover
The potential interplay between mesenchymal stem cells and tumor microenvironment. See Droujinine, Eckert, Zhao. Larger Image.
Table of Contents
Editorial
Reaching Un-Drugable Intracellular Targets with the Long Arm of Antibodies
| Reaching Un-Drugable Intracellular Targets with the Long Arm of Antibodies |
|
https://doi.org/10.18632/oncotarget.1039 David A. Scheinberg, Tao Dao, and Cheng Liu |
| 647-648 |
| PDF | HTML | How to cite |
Perturbation of nucleotide metabolism - the driving force of oncogene-induced senescence
| Perturbation of nucleotide metabolism - the driving force of oncogene-induced senescence |
|
https://doi.org/10.18632/oncotarget.1023 Zbigniew Darzynkiewicz |
| 649-650 |
| PDF | HTML | How to cite |
Reviews
To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells
| To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells |
|
https://doi.org/10.18632/oncotarget.1040 Ilia A. Droujinine, Mark A Eckert, and Weian Zhao |
| 651-664 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
Research Papers
MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1
| MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1 |
|
https://doi.org/10.18632/oncotarget.928 Ariel Bier, Niss Giladi, Noam Kronfeld, Hae Kyung Lee, Simona Cazacu, Susan Finniss, Cunli Xiang, Laila Poisson, Ana C deCarvalho, Shimon Slavin, Elad Jacoby, Michal Yalon, Amos Toren, Tom Mikkelsen, and Chaya Brodie |
| 665-676 |
| Abstract | PDF | HTML | How to cite |
Cell death sensitization of leukemia cells by opioid receptor activation
| Cell death sensitization of leukemia cells by opioid receptor activation |
|
https://doi.org/10.18632/oncotarget.952 Claudia Friesen, Mareike Roscher, Inis Hormann, Iduna Fichtner, Andreas Alt, Ralf Hilger, Klaus-Michael Debatin, and Erich Miltner |
| 677-690 |
| Abstract | PDF | HTML | How to cite |
Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
| Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors |
|
https://doi.org/10.18632/oncotarget.975 Joanna L Gillis, Luke A Selth, Margaret M Centenera, Scott L Townley, Shihua Sun, Stephen R Plymate, Wayne D Tilley, and Lisa M Butler |
| 691-704 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy
| P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy |
|
https://doi.org/10.18632/oncotarget.974 Rabih Said, David S. Hong, Carla L. Warneke, J. Jack Lee, Jennifer J. Wheler, Filip Janku, Aung Naing, Gerald S. Falchook, Siqing Fu, Sarina Piha-Paul, Apostolia M. Tsimberidou, and Razelle Kurzrock |
| 705-714 |
| Abstract | PDF | HTML | How to cite |
Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations
| Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations |
|
https://doi.org/10.18632/oncotarget.990 Jonathan M. Gerber, Jessica L. Gucwa, David Esopi, Meltem Gurel, Michael C. Haffner, Milada Vala, William G. Nelson, Richard J. Jones, and Srinivasan Yegnasubramanian |
| 715-728 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies.
| FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies. |
|
https://doi.org/10.18632/oncotarget.1027 Rocky Cipriano, Kristy L.S. Miskimen, Benjamin L. Bryson, Chase R. Foy, Courtney A. Bartel, and Mark W Jackson |
| 729-738 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer
| Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer |
|
https://doi.org/10.18632/oncotarget.1034 Xiao-Yang Wang, Huina Yu, R. Ilona Linnpoila, Laodong Li, Dangyu Li, Biwen Bo, Hideyuki Okano, Luis O.F. Penalva, and Robert I Glazer |
| 739-750 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108
| Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108 |
|
https://doi.org/10.18632/oncotarget.1044 Karoly Szepeshazi, Andrew V. Schally, Norman L. Block, Gabor Halmos, Mehrdad Nadji, Luca Szalontay, Irving Vidaurre, Andrew Abi-Chaker, and Ferenc G. Rick |
| 751-760 |
| Abstract | PDF | HTML | How to cite |
Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma
| Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma |
|
https://doi.org/10.18632/oncotarget.1047 Ryan T Pitman, Luke Wojdyla, and Neelu Puri |
| 761-771 |
| Abstract | PDF | HTML | How to cite |
Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population
| Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population |
|
https://doi.org/10.18632/oncotarget.1028 Jennifer Wheler, Gerald Falchook, Apostolia M. Tsimberidou, David Hong, Aung Naing, Sarina Piha-Paul, Su S. Chen, John Heymach, Siqing Fu, Su S. Chen, Bettzy Stephen, Jansina Y. Fok, Filip Janku, and Razelle Kurzrock |
| 772-784 |
| Abstract | PDF | HTML | How to cite |
CD44variant exon 9 plays an important role in colon cancer initiating cells
| CD44variant exon 9 plays an important role in colon cancer initiating cells |
|
https://doi.org/10.18632/oncotarget.1048 Youhei Kimura, Takanori Goi, Toshiyuki Nakazawa, Yasuo Hirono, Kanji Katayama, Takeshi Urano, and Akio Yamaguchi |
| 785-791 |
| Abstract | PDF | HTML | How to cite |
Brain Tumor Stem Cell Multipotency Correlates with Nanog Expression and Extent of Passaging in Human Glioblastoma Xenografts
| Brain Tumor Stem Cell Multipotency Correlates with Nanog Expression and Extent of Passaging in Human Glioblastoma Xenografts |
|
https://doi.org/10.18632/oncotarget.1059 Dominique M. Higgins, Ruisi Wang, Brian Milligan, Mark Schroeder, Brett Carlson, Jenny Pokorny, Samuel H. Cheshier, Fredric B. Meyer, Irving L. Weissman, Jann N. Sarkaria, and John R. Henley |
| 792-801 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
Copyright © 2025 Rapamycin Press LLC dba Impact Journals